Barnsdale, Lee and Yeung, Alan and Glancy, Megan and Lang, Jaroslaw and Markoulidakis, Andreas and Hickman, Matthew and Jones, Hayley E and Curnow, Elinor and Trayner, Kirsten M A and Fraser, Rosalyn and Hunt, Gordon and de Wit, Femke and McAuley, Andrew and Hutchinson, Sharon and Shivaji, Tara (2026) Cohort profile: Scotland's Substance Use and Health Intelligence Linked Dataset (SHIeLD). International Journal of Epidemiology, 55, (4), https://doi.org/10.1093/ije/dyag140.
External website: https://academic.oup.com/ije/article/55/4/dyag140/...
The Substance Use and Health Intelligence Linked Dataset (SHIeLD) [1] is a national, population-based, retrospective, linked administrative open cohort of people with problematic drug use in Scotland, with an initial focus on those prescribed opioid agonist therapy (OAT). It is based on multiple administrative databases recording drug-related health harms, treatments, and other exposures held by Public Health Scotland (PHS). SHIeLD was established in 2019 to address three main public health policy and research aims:
-
To estimate the size and composition of Scotland’s population of people dependent on opioids.
-
To establish trends in morbidity, drug-related mortality, and other causes of death among people who use drugs.
-
To assess the impact of OAT and other interventions on morbidity and mortality.
B Substances > Opioids (opiates)
B Substances > New (novel) psychoactive substances > Benzodiazepines
B Substances > New (novel) psychoactive substances > Other novel substances > Gabapentinoids GABA (Pregabalin / Gabapentin)
E Concepts in biomedical areas > Medical substance > Prescription drug (medicine / medication)
G Health and disease > Public health
G Health and disease > Substance use disorder (addiction) > Multiple / concurrent substance use (Poly-drug)
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Viral disease / infection > Coronavirus (COVID-19)
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
P Demography, epidemiology, and history > Population dynamics / statistics > Substance related mortality / death
T Demographic characteristics > Person who uses substances (user / experience)
T Demographic characteristics > Person who injects drugs (Intravenous / injecting)
VA Geographic area > Europe > United Kingdom or Great Britain > Scotland
Repository Staff Only: item control page